CARY — Lucerno Dynamic, LLC today filed with the SEC to disclose a debt-based round of funding so far involving 18 investors. The filing shows nearly $473,000 raised, with a goal of reaching $2 million in funding.

Founded in 2011, the Cary-based company delivers solutions to help reduce negative outcomes during radiation treatments, primarily those related to fluid leakage during IV injections. The company’s “Lara System”, which reached commercialization in 2019, is now available in 15 countries, according to the company website.

Biomarker tech firm Lucerno Dynamics raises another $2.8M

Lucerno has had success in previous funding, starting with the awarding of a $47,000 NC IDEA grant in 2012. The company raised $6.3 million in a 2016 Series A round. Since then the company has mostly done small debt funding, disclosing just under $1.5 million in 3 filings.